News

Campaign to prioritise disabled children as Pfizer vaccine approved for use in 12- to 15-year-olds

2 mins read Health Coronavirus
The Pfizer-Biontech Covid-19 vaccine has been approved for use for 12- to 15-year-olds sparking calls to prioritise diasbled children if it is rolled-out.
The jab has already been approved for young people aged 16 and older. Picture: Adobe Stock
The jab has already been approved for young people aged 16 and older. Picture: Adobe Stock

The announcement has today (4 June) been made by the government’s Medicines and Healthcare products Regulatory Agency (MHRA) and will now be passed to the Joint Committee on Vaccination and Immunisation (JCVI) will now decide if the vaccine will be extended to the age group.

Organisations supporting the families of disabled and clinically vulnerable children say the news has sparked fresh hope for those who have been shielding for more than a year.

They are calling on the JCVI to prioritise these groups if the vaccine programme is rolled-out to children aged 12 and above. The jab has already been approved for use in adults and teenagers over the age of 16.

Register Now to Continue Reading

Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:

What's Included

  • Free access to 4 subscriber-only articles per month

  • Email newsletter providing advice and guidance across the sector

Register

Already have an account? Sign in here


More like this